We are live on ! Find out more
Handelsbanken Fonder

Handelsbanken Fonder Portfolio holdings

AUM $35.1B
1-Year Est. Return 47.76%
This Fund
S&P 500
This Quarter Est. Return
+5.31%
1 Year Est. Return
+47.76%
3 Year Est. Return
+137.96%
5 Year Est. Return
+170.36%
10 Year Est. Return
+934.7%
AUM
$23B
AUM Growth
-$233M
Cap. Flow
-$880M
Cap. Flow %
-3.82%
Top 10 Hldgs %
33.31%
Holding
1,606
New
44
Increased
614
Reduced
449
Closed
86

Top Buys

Rank Stock Value
1
VRTX icon
Vertex Pharmaceuticals
VRTX
+$63.2M
2
EXP icon
Eagle Materials
EXP
+$56.2M
3
ITRI icon
Itron
ITRI
+$54.4M
4
AAPL icon
Apple
AAPL
+$52.6M
5
ENPH icon
Enphase Energy
ENPH
+$40.6M

Top Sells

Rank Stock Value
1
COO icon
Cooper Companies
COO
+$82.8M
2
NVDA icon
NVIDIA
NVDA
+$76M
3
MSFT icon
Microsoft
MSFT
+$62.6M
4
ADBE icon
Adobe
ADBE
+$62.2M
5
JBL icon
Jabil
JBL
+$41M

Sector Composition

Rank Sector Weight
1 Technology 36.79%
2 Healthcare 19.28%
3 Financials 10.14%
4 Communication Services 9.05%
5 Industrials 8.5%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RGLD icon
576
Royal Gold
RGLD
$19.2B
$2.1M 0.01%
16,802
-200
-1% -$25K
AGNC icon
577
AGNC Investment
AGNC
$13B
$2.1M 0.01%
220,100
+114,800
+109% +$1.1M
TOST icon
578
Toast
TOST
$19.9B
$2.1M 0.01%
81,400
-6,600
-8% -$160K
UHS icon
579
Universal Health Services
UHS
$10.1B
$2.09M 0.01%
11,300
-800
-7% -$142K
REG icon
580
Regency Centers
REG
$14.1B
$2.08M 0.01%
33,500
– –
LEGN icon
581
Legend Biotech
LEGN
$3.95B
$2.08M 0.01%
46,900
+7,200
+18% +$332K
EWBC icon
582
East-West Bancorp
EWBC
$18.6B
$2.07M 0.01%
28,300
-4,900
-15% -$363K
PCVX icon
583
Vaxcyte
PCVX
$8.87B
$2.06M 0.01%
27,300
+7,700
+39% +$524K
HRL icon
584
Hormel Foods
HRL
$13.5B
$2.05M 0.01%
67,287
-94,563
-58% -$3.18M
CELH icon
585
Celsius Holdings
CELH
$7.2B
$2.04M 0.01%
35,800
+9,700
+37% +$733K
RIVN icon
586
Rivian
RIVN
$23.1B
$2.04M 0.01%
152,100
-124,257
-45% -$1.3M
CROX icon
587
Crocs
CROX
$6.32B
$2.03M 0.01%
13,900
-130,400
-90% -$18.3M
REXR icon
588
Rexford Industrial Realty
REXR
$8.13B
$2.03M 0.01%
45,502
+7,600
+20% +$342K
CCK icon
589
Crown Holdings
CCK
$13B
$2.01M 0.01%
27,000
-2,500
-8% -$202K
ERIE icon
590
Erie Indemnity
ERIE
$13.3B
$1.98M 0.01%
5,465
– –
GMED icon
591
Globus Medical
GMED
$11.5B
$1.98M 0.01%
28,897
+1,700
+6% +$102K
CFG icon
592
Citizens Financial Group
CFG
$31.3B
$1.97M 0.01%
54,646
-62,050
-53% -$2.16M
AFG icon
593
American Financial Group
AFG
$12B
$1.97M 0.01%
16,000
-3,600
-18% -$463K
NYT icon
594
New York Times
NYT
$10.3B
$1.97M 0.01%
38,404
-3,500
-8% -$165K
TTEK icon
595
Tetra Tech
TTEK
$9.18B
$1.97M 0.01%
48,045
– –
RL icon
596
Ralph Lauren
RL
$23.1B
$1.96M 0.01%
11,200
-107,800
-91% -$18.6M
JEF icon
597
Jefferies Financial Group
JEF
$12.7B
$1.95M 0.01%
39,203
– –
FFIV icon
598
F5
FFIV
$23.7B
$1.95M 0.01%
11,300
– –
CHE icon
599
Chemed
CHE
$7.09B
$1.94M 0.01%
3,572
+500
+16% +$286K
MEDP icon
600
Medpace
MEDP
$16.3B
$1.94M 0.01%
4,700
– –
22 23
24
25 26

Similar funds

Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return
VIA
Vanguard Investments Australia Victoria, Australia $34.6B AUM
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
GAM
Gotham Asset Management New York $32.7B AUM 27.65% 1-Year Est. Return

Handelsbanken Fonder's Q2 2024 Portfolio in Review

As of Q2 2024, Handelsbanken Fonder held 1,606 positions worth $23B, down 1% from $23.2B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Handelsbanken Fonder withdrew a net $880M in Q2 2024, closing 86 positions and reducing 449 holdings. Its most notable exit was Shockwave Medical, Inc. Common Stock, an estimated $20.6M position sold in full.

By sector, the portfolio is most concentrated in Technology at 37% of assets, up from 33% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Handelsbanken Fonder opened a new position in Kenvue worth $12.8M.

  • Handelsbanken Fonder's largest Q2 2024 buy was Kenvue: 701,911 shares worth $12.8M.
  • Handelsbanken Fonder added most to Vertex Pharmaceuticals in Q2 2024, an estimated $63.2M increase.
  • Handelsbanken Fonder's biggest Q2 2024 reduction was Cooper Companies, cutting an estimated $82.8M.
  • Handelsbanken Fonder fully exited Shockwave Medical, Inc. Common Stock in Q2 2024, selling an estimated $20.6M.
  • Handelsbanken Fonder's ten largest holdings make up 33% of its $23B portfolio in Q2 2024.
  • Handelsbanken Fonder opened 44 new positions and closed 86 in Q2 2024.
  • Handelsbanken Fonder's portfolio value fell 1% quarter-over-quarter to $23B.

Based on Handelsbanken Fonder's 13F filing for Q2 2024, filed 5 Aug 2024.